[Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?].
D000917:Antibody Formation; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000276:immunology; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents
Chronická myeloidná leukémia. Nedostatocnosf' liecby konecného stádia podnetom pre zmenu liecebnej taktiky chronickej fázy?